<DOC>
	<DOCNO>NCT00394355</DOCNO>
	<brief_summary>This randomize , multi-center , parallel-group , active-controlled , double-blind study evaluate effect mometasone furoate ( MF ) dry powder inhaler ( DPI ) bone mineral density ( BMD ) subject asthma . The mean percent change lumbar spine BMD average baseline value ( average two scan result prior treatment ) endpoint treatment time point ( average last two valid post-baseline scan result treatment ) comparison MF DPI 400 mcg daily even versus montelukast ( ML ) 10 mg daily evening .</brief_summary>
	<brief_title>Effects Mometasone Furoate Dry Powder Inhaler , Fluticasone Propionate , Montelukast Bone Mineral Density Asthmatics ( Study P03418 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Informed consent , adhere schedule . Inform usual treat medical doctor ( MD ) study participation . Female 18 40 , male 18 50 , race . &gt; =3month asthma history . Never treat inhaled corticosteroid ( ICS ) asthma take ICS ≥3 month prior Screening . Prebronchodilator force expiratory volume ( liter ) 1 second ( FEV1 ) &gt; =60 % &amp; &lt; =90 % predict Screening &amp; Baseline , restrict medication withheld . Prior randomization , demonstrate increase absolute FEV1 &gt; =12 % , absolute volume increase &gt; =200 mL , reversibility test . Lab test normal/acceptable investigator/sponsor . Electrocardiogram ( ECG ) perform screen &lt; 30 day screen normal/acceptable investigator . Chest xray perform screen &lt; 12 month screen normal/acceptable investigator . 25hydroxy vitamin D level &gt; =15 ng/mL . If &lt; 15 , retested take calcium plus vitamin D 4 week . Free significant disease ( asthma ) know affect bone mineral metabolism include renal disease , unstable hyperthyroidism endocrinopathies , Paget 's disease , osteoporosis , malabsorption , others could interfere study evaluation ( eg scoliosis , metal pin , calcification spine/femur ) . Women childbearing potential must use birth control . Includes : hormonal contraceptive , intrauterine device ( IUD ) ; condom combination spermicide ; monogamous relationship male vasectomy use condom . Started method ≥3 month prior Screening ( exception condom ) , &amp; agree continue duration . Women currently sexually active must agree/consent use doublebarrier method become active . Females must negative serum pregnancy test Screening . 2 valid scan , confirm local dual energy xray absorptiometry ( DXA ) center , lumbar spine , leave total femur , &amp; femoral neck prior randomization . Valid scan 2 scan region , perform day , agree within 5 % &amp; scan technically satisfactory ( eg correct scan mode , artifacts present , correct region ) . &gt; 12 inhalations/day salbutamol 2 consecutive day Screening &amp; Baseline . Increase/decrease FEV1 &gt; =20 % Screening &amp; Baseline . Treated methotrexate , cyclosporin , gold , cytotoxic agent , asthma concurrent condition within last 3 month . Pipe/cigar smoke history . Smoker/exsmoker smoke within previous year smoke history ≥10 packyears . Upper/lower respiratory tract infection within 2 week prior Screening &amp; Baseline . Can reschedule . &gt; 14 day oral steroid within previous 12 month require burst systemic steroid within previous month . Ever required ventilator support respiratory failure secondary asthma . Treated emergency room ( ER ) asthma exacerbation admit hospital management airway obstruction 1 occasion last 3 month &gt; =2 occasion within last 6 month . Chronic bronchitis , bronchiectasis , emphysema cystic fibrosis . Participated study within last 30 day . Allergic to/intolerant ICS , betaagonists , drugs/excipients study . Average 2 lumbar spine ( L1L4 ) scan Screening &gt; 2 standard deviation normal . Condition might affect ability ambulate normally , ( ie major surgical procedure ) . Condition may interfere BMD measurement . History renal , hepatic , cardiovascular , metabolic , neurologic , hematologic , respiratory , gastrointestinal , cerebrovascular , could interfere study require treatment might interfere ( eg calcium urolithiasis absorptive hypercalcuria , insulin dependent diabetes , cancer within last 10 year ( except basal cell carcinoma ) , active hepatitis , coronary artery disease , stroke , rheumatoid arthritis , human immunodeficiency virus ( HIV ) , respiratory condition chronic obstructive pulmonary disease ( COPD ) , chronic bronchitis , cystic fibrosis . Others wellcontrolled &amp; stable ( eg hypertension , arrhythmia , subject stable thyroid hormone replacement least 3 month whose thyroid stimulate hormone ( TSH ) level normal ) may allow . Treated within last year drug know interfere bone metabolism include : bisphosphonates , estrogens depot injectables ( estrogen use oral combined hormonal contraceptive allow dose stable throughout ) , highdose fluoride , &amp; thyroid replacement hormone ( stabilize ) . History &amp; /or presence intraocular pressure either eye &gt; =22 mm Hg , glaucoma , &amp; /or posterior subcapsular cataract . History &amp; /or presence nuclear cataract undergone bilateral lens extraction may eligible . The subject undergone incisional intraocular surgery natural lens still present eye . The subject history penetrate trauma eye . The subject one follow lens opacity classification system version III ( LOCS III ) grade screening : nuclear opalescence ( NO ) &gt; =3.0 , nuclear color ( NC ) &gt; =3.0 , cortical ( C ) &gt; =2.0 , posterior ( P ) &gt; =0.5 . Pregnant , breastfeeding , postmenopausal woman . Amenorrhea &gt; 6 month exclude ( exception hysterectomy ) . Bilateral oophorectomy exclude . Relevant abnormal Baseline vital sign . Body mass index ( BMI ) &gt; 35 kg/m2 . HIV positive ( test perform ) . Alcoholic illicit drug abuser . Evidence oropharyngeal candidiasis Baseline without treatment . If evidence Screening , may treat appropriate &amp; visit schedule upon resolution . If evidence Baseline Visit , may treat appropriate &amp; visit reschedule upon resolution . Normal sleep/wake cycle invert ( eg night shift worker ) . Taken restricted medication prior Screening . Can adhere prohibit &amp; permit concomitant medication . No subject may participate study another site simultaneously study . No person directly associate administration study may participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>